StemCell Therapy

May 31, 2017 Researchers from the Institute of Bioengineering and Nanotechnology and the National Cancer Centre Singapore who discovered the approach of using patients stem cells to test for side effects of drugs. From left: Hanry Yu, Min-Han Tan and Ravindran Kanesvaran. Credit: A*STAR Institute of Bioengineering and Nanotechnology

Severe illnesses sometimes require treatment regimens carrying grave risks, including organ failure. Now, a non-invasive technique developed at A*STAR could help predict patient vulnerability to potentially toxic drugs.

Therapeutics can induce organ damage via mechanisms that vary between individuals. These idiosyncratic drug reactions are a common reason for the withdrawal of new drugs, and can be a significant problem during disease treatment.

Research led by Min-Han Tan and Hanry Yu from the Institute of Bioengineering and Nanotechnology, and National Cancer Centre shows how cells derived from a patient's blood offer the first opportunity to test an individual's susceptibility to idiosyncratic liver damage, known as hepatotoxicity; in this case, from the cancer drug, pazopanib.

Currently there is no easy way to predict idiosyncratic harm from the drug, "Pazopanib causes idiosyncratic hepatotoxicity, and liver biopsies are not commonly undertaken due to their invasive nature and potential risks," says Tan.

The researchers took white blood cells from five patients receiving pazopanib for metastatic renal cell cancer, three of whom exhibited hepatotoxicity. They converted these white blood cells into stem cells, and then into 'hepatocyte-like cells' (HLCs). This created a population of cells that retained the genetics and morphology of each patient's native liver cells, without the risks of a biopsy. The stem cells were then treated with pazopanib.

After 24 hours, the HLCs taken from the three patients exhibiting hepatotoxicity also experienced significantly more cell death than those from the two patients without liver damage. This validated that the test can model the individually-mediated effects of pazopanib on the liver.

"Currently, new drugs are tested for toxicity using generic liver cells, which cannot model patient-specific reaction. Establishing patient-specific HLCs with characteristics that are representative of genetic variation will be valuable for pharmaceutical drug testing," says Yu.

The team also discovered the mechanism by which pazopanib causes injury by evaluating the changes in HLC gene expression following drug administration. In cells from both groups of patients, gene expression changes indicated a response to drug-induced stress. HLCs from hepatotoxicity-susceptible individuals, however, also showed evidence of differential iron metabolism as well as other genetic variations from non-susceptible HLCs. This probably contributes to the greater levels of cellular damage and death and provides the first experimental evidence of pazopanib's mechanism of action in idiosyncratic hepatotoxicity.

Tan hopes his team's research could be used in future to predict an individual's response to a proposed treatment. "We plan to expand the approach to different drugs and organs, and determine the nature of drug toxicity," explains Tan. "Our ultimate goal is to benefit patients and clinicians by gaining a better understanding of toxicity."

Explore further: Toxic liver effects of fifteen drugs predicted using computational approach

More information: Yukti Choudhury et al. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity, Scientific Reports (2017). DOI: 10.1038/srep41238

Researchers from Monash University have developed a new drug delivery strategy able to block pain within the nerve cells, in what could be a major development of an immediate and long lasting treatment for pain.

Can a fish with a malformed jaw tell us something about hearing loss in mice and humans? The answer is yes, according to a new publication in Scientific Reports.

A newly developed tissue scanner allows looking under the skin of psoriasis patients. This provides clinically relevant information, such as the structure of skin layers and blood vessels, without the need for contrast agents ...

In the average adult human, there are an estimated 100,000 miles of capillaries, veins and arteriesthe plumbing that carries life-sustaining blood to every part of the body, including vital organs such as the heart and ...

Stress changes our eating habits, but the mechanism may not be purely psychological, research in mice suggests. A study published May 30 in Cell Metabolism found that stressed mouse mothers were more likely to give birth ...

Researchers at the University of Birmingham have made a breakthrough in the understanding of how our genetic make-up can impact on the activity of the immune system and our ability to fight cancer.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Originally posted here:
Individual adverse drug responses could be predicted by a simple blood test - Medical Xpress

This entry was posted on May 31, 2017 at 7:42 pm and is filed under Death by Stem Cells. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |